| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 88 | 2024 | 4673 | 6.010 |
Why?
|
| Cardiac Surgical Procedures | 44 | 2024 | 3627 | 2.850 |
Why?
|
| Hospital Mortality | 23 | 2024 | 5296 | 1.720 |
Why?
|
| Developing Countries | 11 | 2023 | 2862 | 1.360 |
Why?
|
| Pulmonary Veins | 11 | 2021 | 743 | 1.280 |
Why?
|
| Cardiology | 15 | 2023 | 1693 | 1.190 |
Why?
|
| Heart Septal Defects, Ventricular | 5 | 2024 | 477 | 1.110 |
Why?
|
| Risk Adjustment | 11 | 2012 | 601 | 1.090 |
Why?
|
| Malnutrition | 3 | 2024 | 622 | 1.080 |
Why?
|
| Quality Indicators, Health Care | 10 | 2017 | 1790 | 1.080 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 7 | 2015 | 64 | 1.060 |
Why?
|
| Quality Improvement | 18 | 2020 | 3801 | 1.010 |
Why?
|
| Infant | 78 | 2024 | 36164 | 0.990 |
Why?
|
| Constriction, Pathologic | 9 | 2019 | 1097 | 0.970 |
Why?
|
| Child, Preschool | 64 | 2024 | 42217 | 0.840 |
Why?
|
| Infant, Newborn | 57 | 2020 | 26187 | 0.830 |
Why?
|
| Aortic Coarctation | 5 | 2018 | 275 | 0.790 |
Why?
|
| Angioplasty, Balloon | 6 | 2015 | 589 | 0.770 |
Why?
|
| Fontan Procedure | 7 | 2019 | 796 | 0.750 |
Why?
|
| Child | 88 | 2024 | 80134 | 0.720 |
Why?
|
| Pediatrics | 10 | 2020 | 3589 | 0.710 |
Why?
|
| Child Mortality | 3 | 2013 | 199 | 0.710 |
Why?
|
| Tetralogy of Fallot | 4 | 2018 | 618 | 0.620 |
Why?
|
| Family Practice | 1 | 2020 | 507 | 0.590 |
Why?
|
| Infant Mortality | 3 | 2013 | 752 | 0.590 |
Why?
|
| Norwood Procedures | 7 | 2019 | 192 | 0.580 |
Why?
|
| Health Resources | 5 | 2017 | 934 | 0.580 |
Why?
|
| Nutritional Support | 2 | 2018 | 173 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2017 | 192 | 0.560 |
Why?
|
| Surgical Wound Infection | 3 | 2017 | 1530 | 0.560 |
Why?
|
| Public Health Administration | 1 | 2019 | 242 | 0.540 |
Why?
|
| Trisomy | 1 | 2017 | 260 | 0.530 |
Why?
|
| Pulmonary Artery | 6 | 2019 | 1927 | 0.530 |
Why?
|
| Heart Ventricles | 6 | 2019 | 3812 | 0.510 |
Why?
|
| Heart Diseases | 5 | 2023 | 2795 | 0.510 |
Why?
|
| Vascular Diseases | 4 | 2015 | 1160 | 0.510 |
Why?
|
| Length of Stay | 11 | 2024 | 6420 | 0.490 |
Why?
|
| Nutritional Status | 3 | 2024 | 1597 | 0.490 |
Why?
|
| Evaluation Studies as Topic | 2 | 2016 | 1624 | 0.480 |
Why?
|
| Prostheses and Implants | 5 | 2006 | 1276 | 0.480 |
Why?
|
| Hypoplastic Left Heart Syndrome | 9 | 2014 | 594 | 0.460 |
Why?
|
| Heart Septal Defects, Atrial | 5 | 2013 | 451 | 0.460 |
Why?
|
| Cause of Death | 5 | 2018 | 3688 | 0.450 |
Why?
|
| Population Surveillance | 4 | 2020 | 2599 | 0.440 |
Why?
|
| Registries | 16 | 2023 | 8236 | 0.430 |
Why?
|
| Adolescent | 52 | 2024 | 88271 | 0.430 |
Why?
|
| Transposition of Great Vessels | 6 | 2017 | 580 | 0.430 |
Why?
|
| Humans | 168 | 2024 | 761098 | 0.420 |
Why?
|
| Fetal Diseases | 3 | 2014 | 912 | 0.410 |
Why?
|
| Advisory Committees | 6 | 2013 | 788 | 0.410 |
Why?
|
| Databases, Factual | 13 | 2019 | 7969 | 0.410 |
Why?
|
| Hospitals, Pediatric | 8 | 2024 | 1860 | 0.410 |
Why?
|
| Sirolimus | 1 | 2019 | 1540 | 0.410 |
Why?
|
| Palliative Care | 12 | 2019 | 3593 | 0.400 |
Why?
|
| Ambulatory Care | 5 | 2018 | 2769 | 0.400 |
Why?
|
| Cardiology Service, Hospital | 4 | 2010 | 240 | 0.390 |
Why?
|
| Risk Assessment | 18 | 2024 | 24013 | 0.390 |
Why?
|
| Diagnosis-Related Groups | 3 | 2010 | 448 | 0.370 |
Why?
|
| Surgical Procedures, Operative | 3 | 2012 | 1923 | 0.370 |
Why?
|
| Disease Management | 4 | 2018 | 2508 | 0.370 |
Why?
|
| Male | 85 | 2024 | 360675 | 0.370 |
Why?
|
| Child Health Services | 1 | 2016 | 644 | 0.370 |
Why?
|
| Consensus | 1 | 2020 | 3133 | 0.360 |
Why?
|
| Female | 90 | 2024 | 392458 | 0.360 |
Why?
|
| Weight Gain | 2 | 2018 | 2349 | 0.360 |
Why?
|
| Stents | 6 | 2020 | 3177 | 0.350 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2011 | 495 | 0.340 |
Why?
|
| Ventricular Function | 1 | 2011 | 406 | 0.330 |
Why?
|
| Treatment Outcome | 42 | 2021 | 64670 | 0.320 |
Why?
|
| Propanolamines | 2 | 2007 | 163 | 0.320 |
Why?
|
| Retrospective Studies | 40 | 2024 | 80673 | 0.320 |
Why?
|
| Nursing Staff | 1 | 2010 | 113 | 0.320 |
Why?
|
| Thoracic Surgery | 4 | 2023 | 722 | 0.320 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2008 | 164 | 0.310 |
Why?
|
| Carbazoles | 2 | 2007 | 220 | 0.300 |
Why?
|
| Postoperative Complications | 15 | 2024 | 15634 | 0.300 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.300 |
Why?
|
| Intraoperative Complications | 5 | 2011 | 1165 | 0.290 |
Why?
|
| Cross Infection | 1 | 2017 | 1422 | 0.290 |
Why?
|
| Lymphatic System | 2 | 2010 | 253 | 0.290 |
Why?
|
| Risk Factors | 35 | 2024 | 74219 | 0.290 |
Why?
|
| Radiography, Thoracic | 2 | 2013 | 1303 | 0.280 |
Why?
|
| United States | 47 | 2020 | 72337 | 0.280 |
Why?
|
| Quality of Health Care | 9 | 2022 | 4319 | 0.280 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 4189 | 0.270 |
Why?
|
| Child Development | 1 | 2018 | 2302 | 0.270 |
Why?
|
| Sepsis | 2 | 2019 | 2586 | 0.270 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 143 | 0.270 |
Why?
|
| Odds Ratio | 11 | 2017 | 9648 | 0.260 |
Why?
|
| Public Health | 2 | 2023 | 2671 | 0.260 |
Why?
|
| Costs and Cost Analysis | 2 | 2022 | 1664 | 0.260 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2008 | 261 | 0.260 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 440 | 0.250 |
Why?
|
| Preoperative Care | 3 | 2011 | 2242 | 0.240 |
Why?
|
| Delphi Technique | 2 | 2020 | 849 | 0.240 |
Why?
|
| Mental Health Services | 1 | 2016 | 1715 | 0.240 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2012 | 1242 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2005 | 749 | 0.240 |
Why?
|
| Quality Assurance, Health Care | 5 | 2013 | 2165 | 0.230 |
Why?
|
| Time Factors | 20 | 2024 | 39953 | 0.230 |
Why?
|
| Ticlopidine | 1 | 2008 | 730 | 0.220 |
Why?
|
| Bioprosthesis | 1 | 2008 | 591 | 0.220 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2007 | 832 | 0.220 |
Why?
|
| Heart-Assist Devices | 2 | 2011 | 1288 | 0.210 |
Why?
|
| International Cooperation | 3 | 2019 | 1423 | 0.210 |
Why?
|
| Delivery of Health Care, Integrated | 4 | 2011 | 940 | 0.210 |
Why?
|
| Cooperative Behavior | 8 | 2018 | 1505 | 0.200 |
Why?
|
| Exercise | 2 | 2010 | 5872 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5662 | 0.190 |
Why?
|
| Multivariate Analysis | 9 | 2017 | 12058 | 0.190 |
Why?
|
| Health Status | 4 | 2016 | 4077 | 0.190 |
Why?
|
| Societies, Medical | 6 | 2018 | 3923 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2011 | 2981 | 0.180 |
Why?
|
| Logistic Models | 7 | 2017 | 13254 | 0.180 |
Why?
|
| Patient Admission | 2 | 2007 | 1365 | 0.180 |
Why?
|
| Exercise Therapy | 2 | 2010 | 922 | 0.180 |
Why?
|
| Hypertension, Pulmonary | 3 | 2017 | 1585 | 0.180 |
Why?
|
| Survival Analysis | 7 | 2019 | 10083 | 0.180 |
Why?
|
| Clinical Competence | 4 | 2015 | 4786 | 0.180 |
Why?
|
| Benchmarking | 4 | 2018 | 1045 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2003 | 233 | 0.170 |
Why?
|
| Prospective Studies | 14 | 2018 | 54419 | 0.170 |
Why?
|
| Intensive Care Units | 2 | 2024 | 3743 | 0.170 |
Why?
|
| Education, Medical, Continuing | 3 | 2014 | 825 | 0.170 |
Why?
|
| Age Factors | 7 | 2018 | 18385 | 0.170 |
Why?
|
| Gross Domestic Product | 1 | 2019 | 77 | 0.160 |
Why?
|
| Physical Fitness | 1 | 2023 | 742 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1669 | 0.160 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2013 | 1559 | 0.160 |
Why?
|
| Follow-Up Studies | 17 | 2018 | 39121 | 0.160 |
Why?
|
| Relative Value Scales | 1 | 1998 | 84 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2001 | 590 | 0.150 |
Why?
|
| Hemodynamics | 5 | 2011 | 4164 | 0.150 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 536 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2019 | 139 | 0.150 |
Why?
|
| Socioeconomic Factors | 4 | 2023 | 7804 | 0.150 |
Why?
|
| Health Policy | 3 | 2017 | 2680 | 0.150 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2017 | 46 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 2746 | 0.140 |
Why?
|
| Evidence-Based Medicine | 6 | 2011 | 3689 | 0.140 |
Why?
|
| Boston | 8 | 2015 | 9324 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2017 | 247 | 0.140 |
Why?
|
| Program Evaluation | 5 | 2017 | 2487 | 0.140 |
Why?
|
| Patient Care Management | 2 | 2010 | 302 | 0.140 |
Why?
|
| Probability | 5 | 2008 | 2478 | 0.140 |
Why?
|
| Heart Transplantation | 7 | 2011 | 3258 | 0.140 |
Why?
|
| Tunica Intima | 2 | 2017 | 458 | 0.140 |
Why?
|
| Echocardiography | 9 | 2022 | 5006 | 0.140 |
Why?
|
| Critical Pathways | 2 | 2010 | 475 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2013 | 2130 | 0.130 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2017 | 103 | 0.130 |
Why?
|
| Survival Rate | 11 | 2018 | 12727 | 0.130 |
Why?
|
| Device Approval | 2 | 2009 | 163 | 0.130 |
Why?
|
| Quality of Life | 5 | 2022 | 13362 | 0.130 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2016 | 85 | 0.130 |
Why?
|
| Drug and Narcotic Control | 1 | 2017 | 144 | 0.130 |
Why?
|
| Pulmonary Atresia | 2 | 2008 | 159 | 0.130 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 989 | 0.130 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2013 | 148 | 0.130 |
Why?
|
| Medical Audit | 1 | 2017 | 453 | 0.130 |
Why?
|
| Protein-Losing Enteropathies | 2 | 2008 | 45 | 0.130 |
Why?
|
| Hospital Costs | 2 | 2013 | 947 | 0.130 |
Why?
|
| Electrocardiography | 6 | 2010 | 6385 | 0.120 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 5427 | 0.120 |
Why?
|
| Heart Failure | 5 | 2013 | 11701 | 0.120 |
Why?
|
| Denmark | 1 | 2017 | 770 | 0.120 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 497 | 0.120 |
Why?
|
| Bottle Feeding | 1 | 2014 | 67 | 0.120 |
Why?
|
| Social Class | 1 | 2023 | 1993 | 0.120 |
Why?
|
| Psychometrics | 3 | 2020 | 3061 | 0.120 |
Why?
|
| Stroke Volume | 3 | 2012 | 5520 | 0.120 |
Why?
|
| Hospital Charges | 3 | 2005 | 350 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2004 | 576 | 0.110 |
Why?
|
| Equipment Failure | 3 | 2006 | 579 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2003 | 2024 | 0.110 |
Why?
|
| Cardiac Output | 2 | 2010 | 831 | 0.110 |
Why?
|
| Morbidity | 4 | 2020 | 1750 | 0.110 |
Why?
|
| American Heart Association | 3 | 2010 | 1043 | 0.110 |
Why?
|
| Eisenmenger Complex | 1 | 2013 | 26 | 0.110 |
Why?
|
| Adult | 32 | 2023 | 221083 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 2 | 2021 | 877 | 0.110 |
Why?
|
| Body Height | 2 | 2018 | 1565 | 0.110 |
Why?
|
| Young Adult | 12 | 2023 | 59199 | 0.110 |
Why?
|
| Infant Formula | 1 | 2014 | 194 | 0.110 |
Why?
|
| Confidence Intervals | 3 | 2016 | 2927 | 0.110 |
Why?
|
| Postoperative Care | 2 | 2017 | 1469 | 0.100 |
Why?
|
| Hospitalization | 2 | 2016 | 10712 | 0.100 |
Why?
|
| Internationality | 1 | 2018 | 1000 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1472 | 0.100 |
Why?
|
| Inservice Training | 1 | 2015 | 375 | 0.100 |
Why?
|
| Nursing Staff, Hospital | 2 | 2017 | 348 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1401 | 0.100 |
Why?
|
| Research Report | 1 | 2015 | 367 | 0.100 |
Why?
|
| Equipment Design | 6 | 2009 | 3509 | 0.100 |
Why?
|
| Off-Label Use | 2 | 2017 | 185 | 0.100 |
Why?
|
| Patient Care Team | 4 | 2017 | 2513 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2015 | 3603 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4849 | 0.100 |
Why?
|
| Fetal Heart | 2 | 2006 | 281 | 0.100 |
Why?
|
| Exercise Test | 4 | 2010 | 2165 | 0.100 |
Why?
|
| Phlebography | 1 | 2013 | 326 | 0.100 |
Why?
|
| Mass Screening | 1 | 2007 | 5425 | 0.100 |
Why?
|
| Catheterization | 2 | 2011 | 1428 | 0.100 |
Why?
|
| Survivors | 3 | 2016 | 2369 | 0.100 |
Why?
|
| Workload | 2 | 2011 | 844 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6482 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2019 | 1185 | 0.090 |
Why?
|
| Operating Room Nursing | 1 | 2011 | 25 | 0.090 |
Why?
|
| Twins, Conjoined | 2 | 2002 | 41 | 0.090 |
Why?
|
| Pulmonary Valve | 2 | 1993 | 411 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2016 | 869 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2021 | 1909 | 0.090 |
Why?
|
| Age of Onset | 2 | 2012 | 3307 | 0.090 |
Why?
|
| Primary Health Care | 3 | 2017 | 4673 | 0.090 |
Why?
|
| Wound Healing | 2 | 2001 | 2801 | 0.090 |
Why?
|
| Nursing Service, Hospital | 1 | 2010 | 17 | 0.090 |
Why?
|
| Oxygen Consumption | 3 | 2023 | 1866 | 0.090 |
Why?
|
| Vinblastine | 1 | 2011 | 488 | 0.090 |
Why?
|
| Pediatric Nursing | 1 | 2011 | 104 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6305 | 0.090 |
Why?
|
| Health Care Costs | 2 | 2017 | 3238 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1422 | 0.080 |
Why?
|
| Lymphography | 1 | 2010 | 188 | 0.080 |
Why?
|
| Life Tables | 3 | 2006 | 364 | 0.080 |
Why?
|
| Cohort Studies | 9 | 2015 | 41486 | 0.080 |
Why?
|
| Terminology as Topic | 2 | 2008 | 1528 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 2 | 2010 | 1274 | 0.080 |
Why?
|
| Cardiotonic Agents | 2 | 2011 | 540 | 0.080 |
Why?
|
| Medicaid | 1 | 2002 | 2814 | 0.080 |
Why?
|
| Blood Flow Velocity | 2 | 2010 | 1374 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 1489 | 0.080 |
Why?
|
| Safety | 2 | 2010 | 1151 | 0.080 |
Why?
|
| Organizational Objectives | 4 | 2011 | 426 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15845 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 190 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2018 | 1286 | 0.080 |
Why?
|
| Embolism | 2 | 2015 | 399 | 0.080 |
Why?
|
| Medical Records | 1 | 2014 | 1409 | 0.080 |
Why?
|
| Mortality | 2 | 2017 | 2896 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1187 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2016 | 20120 | 0.070 |
Why?
|
| Heart Bypass, Right | 2 | 2008 | 75 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1577 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 7 | 2013 | 7400 | 0.070 |
Why?
|
| Gestational Age | 2 | 2014 | 3577 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1997 | 1490 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 828 | 0.070 |
Why?
|
| Observer Variation | 1 | 2013 | 2611 | 0.070 |
Why?
|
| United States Food and Drug Administration | 3 | 2017 | 1661 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2008 | 473 | 0.070 |
Why?
|
| Child Welfare | 2 | 2008 | 521 | 0.070 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 3882 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 710 | 0.070 |
Why?
|
| Massachusetts | 2 | 2016 | 8836 | 0.070 |
Why?
|
| Tricuspid Valve | 3 | 2006 | 410 | 0.070 |
Why?
|
| Vena Cava, Superior | 2 | 2006 | 196 | 0.070 |
Why?
|
| Pilot Projects | 4 | 2020 | 8639 | 0.070 |
Why?
|
| Prosthesis Implantation | 2 | 2001 | 591 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2014 | 1355 | 0.070 |
Why?
|
| Prevalence | 3 | 2018 | 15717 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2013 | 15308 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1223 | 0.060 |
Why?
|
| Middle Aged | 13 | 2020 | 220835 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 2 | 2013 | 1305 | 0.060 |
Why?
|
| Learning | 1 | 2015 | 1739 | 0.060 |
Why?
|
| Health Services Research | 4 | 2013 | 1807 | 0.060 |
Why?
|
| Case-Control Studies | 6 | 2015 | 22157 | 0.060 |
Why?
|
| Gadolinium | 1 | 2010 | 961 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 1674 | 0.060 |
Why?
|
| Medical Errors | 1 | 2014 | 1263 | 0.060 |
Why?
|
| Career Choice | 1 | 2012 | 757 | 0.060 |
Why?
|
| Heart Atria | 3 | 1997 | 1349 | 0.060 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 390 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2012 | 8000 | 0.060 |
Why?
|
| Body Surface Potential Mapping | 2 | 1997 | 228 | 0.060 |
Why?
|
| Methotrexate | 1 | 2011 | 1717 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2855 | 0.060 |
Why?
|
| Interdisciplinary Communication | 4 | 2011 | 928 | 0.060 |
Why?
|
| Electrodes | 3 | 1997 | 611 | 0.060 |
Why?
|
| Curriculum | 2 | 2015 | 3739 | 0.060 |
Why?
|
| Reoperation | 4 | 2021 | 4304 | 0.060 |
Why?
|
| Continuity of Patient Care | 3 | 2023 | 1067 | 0.060 |
Why?
|
| Radiography | 4 | 2015 | 6975 | 0.060 |
Why?
|
| Aged | 8 | 2019 | 169266 | 0.060 |
Why?
|
| California | 3 | 2011 | 1431 | 0.060 |
Why?
|
| ROC Curve | 2 | 2010 | 3582 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2017 | 1837 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2006 | 1086 | 0.060 |
Why?
|
| National Health Programs | 1 | 2007 | 440 | 0.060 |
Why?
|
| Angiography | 2 | 2021 | 1597 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1424 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 2316 | 0.060 |
Why?
|
| Comorbidity | 2 | 2012 | 10514 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2010 | 1051 | 0.050 |
Why?
|
| Walking | 1 | 2010 | 1194 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 4013 | 0.050 |
Why?
|
| India | 2 | 2023 | 2287 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2009 | 350 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1780 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2001 | 352 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2010 | 2424 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2012 | 2106 | 0.050 |
Why?
|
| Fetofetal Transfusion | 2 | 2002 | 112 | 0.050 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 14676 | 0.050 |
Why?
|
| Cost Savings | 3 | 2013 | 912 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2007 | 838 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2020 | 5971 | 0.050 |
Why?
|
| Catheter Ablation | 3 | 1997 | 2751 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2007 | 2278 | 0.050 |
Why?
|
| Europe | 1 | 2008 | 3422 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3450 | 0.050 |
Why?
|
| Heart Rate | 2 | 2010 | 4196 | 0.050 |
Why?
|
| Stroke | 3 | 2018 | 9720 | 0.050 |
Why?
|
| Age Distribution | 1 | 2007 | 2873 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 1122 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2000 | 79 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2013 | 2115 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2013 | 8478 | 0.050 |
Why?
|
| Foreign-Body Reaction | 1 | 2001 | 157 | 0.050 |
Why?
|
| Incidence | 5 | 2018 | 21357 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2022 | 1754 | 0.040 |
Why?
|
| Social Adjustment | 1 | 2003 | 632 | 0.040 |
Why?
|
| Heart | 2 | 2010 | 4431 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2008 | 1126 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 10213 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 1462 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2007 | 1067 | 0.040 |
Why?
|
| Embolism, Paradoxical | 1 | 2000 | 54 | 0.040 |
Why?
|
| Coronary Angiography | 3 | 2006 | 4506 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 278 | 0.040 |
Why?
|
| Program Development | 3 | 2010 | 1292 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4060 | 0.040 |
Why?
|
| Aortic Valve | 2 | 2004 | 1959 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4822 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3094 | 0.040 |
Why?
|
| Endocardium | 2 | 1997 | 248 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 3 | 2021 | 5494 | 0.040 |
Why?
|
| Risk | 1 | 2011 | 9614 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 6504 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1304 | 0.040 |
Why?
|
| Sheep | 3 | 2000 | 1436 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 1624 | 0.040 |
Why?
|
| Fee Schedules | 1 | 1998 | 87 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3568 | 0.040 |
Why?
|
| Prognosis | 4 | 2011 | 29672 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 854 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 6178 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 934 | 0.040 |
Why?
|
| Child Advocacy | 1 | 2017 | 48 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 2 | 1997 | 273 | 0.040 |
Why?
|
| Income | 1 | 2006 | 1868 | 0.040 |
Why?
|
| Medicare Part B | 1 | 1998 | 117 | 0.040 |
Why?
|
| Algorithms | 3 | 2013 | 14023 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2005 | 1510 | 0.030 |
Why?
|
| Pregnancy | 5 | 2022 | 29872 | 0.030 |
Why?
|
| Drug Approval | 2 | 2017 | 812 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3535 | 0.030 |
Why?
|
| Device Removal | 1 | 2001 | 630 | 0.030 |
Why?
|
| Quebec | 1 | 2016 | 140 | 0.030 |
Why?
|
| Lung | 2 | 2015 | 9979 | 0.030 |
Why?
|
| Pakistan | 1 | 2017 | 292 | 0.030 |
Why?
|
| Educational Status | 1 | 2024 | 2510 | 0.030 |
Why?
|
| Cognition | 1 | 2014 | 6987 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2003 | 793 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2001 | 1204 | 0.030 |
Why?
|
| Therapeutics | 1 | 2016 | 113 | 0.030 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2003 | 1351 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2017 | 188 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2018 | 26068 | 0.030 |
Why?
|
| Random Allocation | 1 | 2000 | 2393 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2008 | 4479 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 566 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 20600 | 0.030 |
Why?
|
| Amiloride | 1 | 1985 | 116 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2000 | 874 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2007 | 3410 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2013 | 36418 | 0.030 |
Why?
|
| Policy Making | 1 | 2017 | 541 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2000 | 2247 | 0.030 |
Why?
|
| Defibrillators, Implantable | 2 | 2013 | 1492 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 1266 | 0.030 |
Why?
|
| Body Weight | 3 | 2011 | 4618 | 0.030 |
Why?
|
| Government Regulation | 1 | 2017 | 524 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 1998 | 667 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2005 | 7043 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 2944 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 1496 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2013 | 1017 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2632 | 0.020 |
Why?
|
| Swine | 2 | 2010 | 5909 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 2018 | 0.020 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2013 | 140 | 0.020 |
Why?
|
| Platinum | 1 | 2013 | 220 | 0.020 |
Why?
|
| Critical Care | 2 | 2017 | 2690 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 726 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2001 | 2000 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 1989 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2013 | 426 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 1535 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10755 | 0.020 |
Why?
|
| Accreditation | 1 | 2014 | 473 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 1257 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 403 | 0.020 |
Why?
|
| Dendrimers | 1 | 2010 | 73 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 163 | 0.020 |
Why?
|
| Ion Channels | 1 | 1985 | 1039 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2011 | 223 | 0.020 |
Why?
|
| Infection Control | 1 | 2017 | 983 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1498 | 0.020 |
Why?
|
| Echocardiography, Stress | 1 | 2010 | 135 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 343 | 0.020 |
Why?
|
| Sodium | 1 | 1985 | 1589 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 501 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4226 | 0.020 |
Why?
|
| Patient Selection | 2 | 2011 | 4245 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2008 | 57 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 436 | 0.020 |
Why?
|
| Therapies, Investigational | 1 | 2009 | 111 | 0.020 |
Why?
|
| Linear Models | 1 | 1998 | 5869 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 513 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6224 | 0.020 |
Why?
|
| Furosemide | 1 | 2008 | 170 | 0.020 |
Why?
|
| Classification | 1 | 2008 | 127 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2577 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 709 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 459 | 0.020 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2007 | 69 | 0.020 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2008 | 152 | 0.020 |
Why?
|
| Guatemala | 1 | 2007 | 159 | 0.020 |
Why?
|
| Brazil | 1 | 2011 | 1229 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 573 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 767 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2010 | 435 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2000 | 6225 | 0.020 |
Why?
|
| Waiting Lists | 2 | 2001 | 765 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5249 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 594 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15513 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2630 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 958 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2682 | 0.020 |
Why?
|
| Recurrence | 2 | 2013 | 8456 | 0.020 |
Why?
|
| Heart Septum | 1 | 2006 | 301 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1504 | 0.020 |
Why?
|
| Forecasting | 2 | 2006 | 2928 | 0.020 |
Why?
|
| Epinephrine | 1 | 2008 | 792 | 0.020 |
Why?
|
| Heart Arrest | 2 | 2010 | 1514 | 0.010 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2009 | 452 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2007 | 577 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2010 | 735 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 763 | 0.010 |
Why?
|
| Home Care Services | 1 | 2011 | 647 | 0.010 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2010 | 659 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2011 | 845 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2009 | 970 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10552 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2114 | 0.010 |
Why?
|
| Outpatients | 1 | 2012 | 1596 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2013 | 5333 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2000 | 12467 | 0.010 |
Why?
|
| Sample Size | 1 | 2007 | 841 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6343 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 80 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 9001 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 290 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 1554 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 982 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 1724 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 1516 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58946 | 0.010 |
Why?
|
| Germany | 1 | 2004 | 872 | 0.010 |
Why?
|
| Parents | 1 | 2016 | 3564 | 0.010 |
Why?
|
| Dopamine | 1 | 2008 | 1606 | 0.010 |
Why?
|
| Ventricular Function, Right | 2 | 1997 | 617 | 0.010 |
Why?
|
| Skin | 1 | 1985 | 4473 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 898 | 0.010 |
Why?
|
| Inpatients | 1 | 2012 | 2545 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 4922 | 0.010 |
Why?
|
| Population Dynamics | 1 | 2002 | 308 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 4749 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2003 | 947 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3461 | 0.010 |
Why?
|
| Animals | 6 | 2010 | 168083 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2000 | 18217 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2013 | 3268 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2011 | 3441 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5311 | 0.010 |
Why?
|
| Atrial Function, Right | 1 | 1997 | 32 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2002 | 803 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1303 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 17349 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1997 | 110 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10421 | 0.010 |
Why?
|
| Rana catesbeiana | 1 | 1985 | 85 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1985 | 213 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1985 | 199 | 0.010 |
Why?
|
| Photolysis | 1 | 1985 | 94 | 0.010 |
Why?
|
| Atrial Flutter | 1 | 1997 | 252 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 3899 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2003 | 2420 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 1263 | 0.010 |
Why?
|
| Hypertension | 1 | 2013 | 8537 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11066 | 0.010 |
Why?
|
| Blood Volume | 1 | 1993 | 547 | 0.010 |
Why?
|
| Methylation | 1 | 1985 | 1070 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 2757 | 0.010 |
Why?
|
| Cicatrix | 1 | 1997 | 793 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1937 | 0.010 |
Why?
|
| Health Behavior | 1 | 2002 | 2641 | 0.010 |
Why?
|
| Epithelium | 1 | 1985 | 1603 | 0.010 |
Why?
|
| Caregivers | 1 | 2002 | 2241 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2002 | 2494 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13506 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1985 | 2189 | 0.000 |
Why?
|
| Coronary Circulation | 1 | 1993 | 1611 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 6312 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 14607 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1985 | 3665 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 3770 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81324 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1985 | 18926 | 0.000 |
Why?
|